Toxicologic Pathology Forum: Considerations Regarding Determination of Adversity for Immunopathology Findings in Nonclinical Toxicology Studies with Immune-Modulating Therapeutics.
Saved in:
| Title: | Toxicologic Pathology Forum: Considerations Regarding Determination of Adversity for Immunopathology Findings in Nonclinical Toxicology Studies with Immune-Modulating Therapeutics. |
|---|---|
| Authors: | Papenfuss TL; StageBio, Mount Jackson, Virginia, USA., Himmel L; AbbVie Inc., North Chicago, Illinois, USA., Kuper CF; Independent Consultant, Utrecht, The Netherlands., Mohanan S; Gilead Sciences, Foster City, California, USA., Harleman J; Independent Consultant, Darmstadt, Germany., Elmore SA; ElmorePathology LLC, Chapel Hill, North Carolina, USA. |
| Source: | Toxicologic pathology [Toxicol Pathol] 2023 Jun; Vol. 51 (4), pp. 205-215. Date of Electronic Publication: 2023 Aug 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Publications Country of Publication: United States NLM ID: 7905907 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-1601 (Electronic) Linking ISSN: 01926233 NLM ISO Abbreviation: Toxicol Pathol Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37578155 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Toxicologic Pathology Forum: Considerations Regarding Determination of Adversity for Immunopathology Findings in Nonclinical Toxicology Studies with Immune-Modulating Therapeutics. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Papenfuss+TL%22">Papenfuss TL</searchLink>; StageBio, Mount Jackson, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Himmel+L%22">Himmel L</searchLink>; AbbVie Inc., North Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Kuper+CF%22">Kuper CF</searchLink>; Independent Consultant, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Mohanan+S%22">Mohanan S</searchLink>; Gilead Sciences, Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Harleman+J%22">Harleman J</searchLink>; Independent Consultant, Darmstadt, Germany.<br /><searchLink fieldCode="AU" term="%22Elmore+SA%22">Elmore SA</searchLink>; ElmorePathology LLC, Chapel Hill, North Carolina, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227905907%22">Toxicologic pathology</searchLink> [Toxicol Pathol] 2023 Jun; Vol. 51 (4), pp. 205-215. <i>Date of Electronic Publication: </i>2023 Aug 14. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage+Publications%22">Sage Publications </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7905907 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1533-1601 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201926233%22">01926233 </searchLink><i>NLM ISO Abbreviation: </i>Toxicol Pathol <i>Subsets: </i>MEDLINE; PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37578155 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1177/01926233231190382 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 205 Titles: – TitleFull: Toxicologic Pathology Forum: Considerations Regarding Determination of Adversity for Immunopathology Findings in Nonclinical Toxicology Studies with Immune-Modulating Therapeutics. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Papenfuss TL – PersonEntity: Name: NameFull: Himmel L – PersonEntity: Name: NameFull: Kuper CF – PersonEntity: Name: NameFull: Mohanan S – PersonEntity: Name: NameFull: Harleman J – PersonEntity: Name: NameFull: Elmore SA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2023 Jun Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1533-1601 Numbering: – Type: volume Value: 51 – Type: issue Value: 4 Titles: – TitleFull: Toxicologic pathology Type: main |
| ResultId | 1 |